In conclusion, our findings determined new anti-tumor mechanisms of acacetin, and also found that acacetin induces p53 expression, which in turn regulates the expression of miR-34a, and that miR-34a is an important mediator on the anti-cancerous effects of acacetin in NSCLC. This evidence concerns the gene TP53 and non-small cell lung carcinoma.